Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

The FDA has approved clesrovimab, marketed as Enflonsia, for the prevention of RSV lower respiratory tract disease in neonates and infants during their first RSV season. ENFLONSIA is a preventive, ...

The new members include some vaccine critics. Doctors say another tool to fight RSV can’t come soon enough. RSV is very common — most kids get it by age 2, according to the CDC. For older children and ...

RSV can be spread through droplets in the air or through direct contact. Children with RSV disease may have mild symptoms such as coughing, runny nose, and fever. However, the disease can progress to ...

Doctors say another tool to fight RSV can’t come soon enough. RSV is very common — most kids get it by age 2, according to the CDC. For older children and adults, it often feels like a cold.